Skip to main content

DeuterOncology NV

DeuterOncology is a clinical-stage drug development company. Its lead product, DO-2, is a deuterated MET kinase inhibitor that is brain penetrant and is being developed as a potential ‘best in class’ targeted therapy for MET driven disease. MET-inhibitors shows success in NSCLC however these treatments are hindered by the toxic…

Read More


Expertise in Data Sciences and Artificial Intelligence in Healthcare, towards Research & Development, Bio-manufacturing and Public Health DNAlytics provides data science expertise for healthcare, including data management, bio-informatics, bio-statistics, extending to Machine Learning and other Artificial Intelligence techniques. Our solutions prove attractive in clinical research, in drug and med-tech development,...
Read More

Secure your place for BioWin Day: empowering health, the premier event for professionals and decision-makers in the life sciences industry.

Register here!